CLINICAL IMPACT
SANI is an adjunctive Clinical Decision Support (CDS) platform designed to eliminate the "Unmonitored Interval." We replace reactive alarms with a proactive safety net that provides continuous visibility throughout the patient's entire environment.
Phased Surveillance for Respiratory Decline
RESPIRATORY SAFETY & OPIOID STEWARDSHIP
The Objective: To identify the earliest prodromal signatures of respiratory instability, allowing for proactive bedside intervention hours before a critical event or desaturation occurs.
The SANI Impact: Standard spot-check vitals often fail to detect the non-linear physiological decline associated with sedation. SANI monitors the continuous trajectory of patient stability using proprietary logic designed to detect behavioral biomarkers during the "prodromal" phase. This ensures high-acuity visibility without the compliance issues of contact-based sensors.
Extended Room-Scale Fall Protection
MOBILITY & PATIENT SAFETY
The Objective: To provide a continuous safety net that extends beyond the bed, monitoring patient stability from the moment of egress through the entire duration of ambulation.
The SANI Impact: Standard safety systems are limited to detecting when a patient has already vacated the bed. SANI provides superior coverage by maintaining surveillance as the patient moves through the room. The system is designed to identify signs of unstable gait and loss of balance while the patient is walking—detecting risks and reporting fall events that standard "smart beds" miss once the patient is in motion.
Early Detection of Hemodynamic Drift
HEART FAILURE & READMISSION REDUCTION
The Objective: To detect objective physiological markers of fluid overload and cardiac instability days before they manifest in a way that requires rehospitalization.
The SANI Impact: Current post-acute monitoring often relies on subjective reporting or lagging indicators like daily weight. SANI utilizes proprietary logic to track objective trends that indicate a shift in stability well before symptoms become acute. This capability is designed to facilitate early medication adjustments in home or hospice settings, specifically targeting the reduction of 30-day readmission rates.
IN DEVELOPMENT / INVESTIGATIONAL
Sepsis Risk Stratification
SANI is currently validating automated protocols designed to identify the earliest physiological signatures of hemodynamic drift associated with sepsis. This capability aims to provide objective data that correlates with institutional sepsis protocols to drive faster time-to-intervention.
Regulatory Notice: The SANI Guardian Platform is a Clinical Decision Support (CDS) tool. It is not intended to diagnose, cure, mitigate, treat, or prevent any disease. All clinical conclusions must be verified by a licensed healthcare professional.